Company

InGel Therapeutics, Inc.

Biotechnology Research Boston, United States 8 employees

Employees: 8
Contacts: 3
Emails: 3
Phones: 3

www.ingeltx.com LinkedIn Crunchbase

InGel Therapeutics, Inc. Overview

Headquarters: Boston, United States
Website: www.ingeltx.com
Industry: Biotechnology Research
Employees: 8
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in biomaterials and retinal stem cells to create a unique product to enable whole functional eye transplantation.

About InGel Therapeutics, Inc.

InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.

InGel Therapeutics, Inc. Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

InGel Therapeutics, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rita Watkins	Senior Director, Commercial Training	Chicago, Illinois, United States	View
Vinit Nijhawan (he/him)	Investor, Entrepreneur, Academic	Cambridge, Massachusetts, United States	Email Phone
Christopher Ghadban	Head Lifesci Investing @ Tvc - Founder	United States	Email Phone
Darius M. Moshfeghi	Professor & Chief of Retina, Stanford	Stanford, California, United States	Email Phone